Biomarkers Database: Obesity, Cognition, and Inflammation

Garcia-Mazcorro, J. F., Mills, D. A., Murphy, K., & Noratto, G. (2018). Effect of barley supplementation on the fecal microbiota, caecal biochemistry, and key biomarkers of obesity and inflammation in obese db/db mice. European Journal of Nutrition, 57(7), 2513–2528. https://doi.org/10.1007/s00394-017-1523-y

Ghosh, S., Murinova, L., Trnovec, T., Loffredo, C. A., Washington, K., Mitra, P. S., & Dutta, S. K. (2014). Biomarkers linking PCB exposure and obesity. Current Pharmaceutical Biotechnology, 15(11), 1058–1068.

Goguet-Rubio, P., Klug, R. L., Sharma, D. L., Srikanthan, K., Puri, N., Lakhani, V. H., … Sodhi, K. (2017). Existence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia. International Journal of Medical Sciences, 14(6), 543–553. https://doi.org/10.7150/ijms.18988

Hawkins, M. a. W., Colaizzi, J., Gunstad, J., Hughes, J. W., Mullins, L. L., Betts, N., … Lovallo, W. R. (2018). Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments. Contemporary Clinical Trials, 66, 20–27. https://doi.org/10.1016/j.cct.2017.12.010

Hilger-Kolb, J., Bosle, C., Motoc, I., & Hoffmann, K. (2017). Associations between dietary factors and obesity-related biomarkers in healthy children and adolescents – a systematic review. Nutrition Journal, 16(1), 85. https://doi.org/10.1186/s12937-017-0300-3

Hulsmans, M., & Holvoet, P. (2013). MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases. Current Pharmaceutical Design, 19(32), 5704–5717.

Indumathy, J., Pal, G. K., Pal, P., Ananthanarayanan, P. H., Parija, S. C., Balachander, J., & Dutta, T. K. (2015). Association of sympathovagal imbalance with obesity indices, and abnormal metabolic biomarkers and cardiovascular parameters. Obesity Research & Clinical Practice, 9(1), 55–66. https://doi.org/10.1016/j.orcp.2014.01.007

Iwasaki, M., Le Marchand, L., Franke, A. A., Hamada, G. S., Miyajima, N. T., Sharma, S., … Tsugane, S. (2016). Comparison of plasma levels of obesity-related biomarkers among Japanese populations in Tokyo, Japan, São Paulo, Brazil, and Hawaii, USA. European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), 25(1), 41–49. https://doi.org/10.1097/CEJ.0000000000000123

Jacobs, C. A., Vranceanu, A.-M., Thompson, K. L., & Lattermann, C. (2018). Rapid Progression of Knee Pain and Osteoarthritis Biomarkers Greatest for Patients with Combined Obesity and Depression: Data from the Osteoarthritis Initiative. Cartilage, 1947603518777577. https://doi.org/10.1177/1947603518777577

Ji, Y., Park, S., Chung, Y., Kim, B., Park, H., Huang, E., … Holzapfel, W. H. (2019). Amelioration of obesity-related biomarkers by Lactobacillus sakei CJLS03 in a high-fat diet-induced obese murine model. Scientific Reports, 9(1), 6821. https://doi.org/10.1038/s41598-019-43092-y

Kannan, S., Acosta, L. M., Acevedo-Garcia, D., Divjan, A., Bracero, L. A., Perzanowski, M. S., & Chew, G. L. (2013). Sociocultural characteristics, obesity and inflammatory biomarkers in Puerto Rican toddlers born in New York City. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, 24(5), 487–492. https://doi.org/10.1111/pai.12084

Katsareli, E. A., & Dedoussis, G. V. (2014). Biomarkers in the field of obesity and its related comorbidities. Expert Opinion on Therapeutic Targets, 18(4), 385–401. https://doi.org/10.1517/14728222.2014.882321

Kim, D.-H., Kim, H., Jeong, D., Kang, I.-B., Chon, J.-W., Kim, H.-S., … Seo, K.-H. (2017). Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. The Journal of Nutritional Biochemistry, 44, 35–43. https://doi.org/10.1016/j.jnutbio.2017.02.014

Lafortuna, C. L., Tovar, A. R., Rastelli, F., Tabozzi, S. A., Caramenti, M., Orozco-Ruiz, X., … Bertoli, G. (2017). Clinical, functional, behavioural and epigenomic biomarkers of obesity. Frontiers in Bioscience (Landmark Edition), 22, 1655–1681.

Levy, E., Saenger, A. K., Steffes, M. W., & Delvin, E. (2017). Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers. EJIFCC, 28(1), 6–24.

Lloret-Linares, C., Miyauchi, E., Luo, H., Labat, L., Bouillot, J.-L., Poitou, C., … Declèves, X. (2016). Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers. Molecular Pharmaceutics, 13(3), 766–773. https://doi.org/10.1021/acs.molpharmaceut.5b00656

Lorente-Cebrián, S., González-Muniesa, P., Milagro, F. I., & Martínez, J. A. (2019). MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets. Clinical Science (London, England: 1979), 133(1), 23–40. https://doi.org/10.1042/CS20180890

Lubrano, C., Valacchi, G., Specchia, P., Gnessi, L., Rubanenko, E. P., Shuginina, E. A., … De Luca, C. (2015). Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome. Oxidative Medicine and Cellular Longevity, 2015, 490613. https://doi.org/10.1155/2015/490613

Luciano, R., Barraco, G. M., Muraca, M., Ottino, S., Spreghini, M. R., Sforza, R. W., … Manco, M. (2015). Biomarkers of Alzheimer disease, insulin resistance, and obesity in childhood. Pediatrics, 135(6), 1074–1081. https://doi.org/10.1542/peds.2014-2391

MacKintosh, M. L., Derbyshire, A. E., McVey, R. J., Bolton, J., Nickkho-Amiry, M., Higgins, C. L., … Crosbie, E. J. (2019). The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. International Journal of Cancer, 144(3), 641–650. https://doi.org/10.1002/ijc.31913

Marcondes, J. P. de C., Andrade, P. F. B., Sávio, A. L. V., Silveira, M. A. D., Rudge, M. V. C., & Salvadori, D. M. F. (2018). BCL2 and miR-181a transcriptional alterations in umbilical-cord blood cells can be putative biomarkers for obesity. Mutation Research. Genetic Toxicology and Environmental Mutagenesis, 836(Pt B), 90–96. https://doi.org/10.1016/j.mrgentox.2018.06.009

Miller, A. L., Lee, H. J., & Lumeng, J. C. (2015). Obesity-associated biomarkers and executive function in children. Pediatric Research, 77(1–2), 143–147. https://doi.org/10.1038/pr.2014.158

Montilla, M., Santi, M. J., Carrozas, M. A., & Ruiz, F. A. (2014). Biomarkers of the prothrombotic state in abdominal obesity. Nutricion Hospitalaria, 31(3), 1059–1066. https://doi.org/10.3305/nh.2015.31.3.8168

Mozafarizadeh, M., Mohammadi, M., Sadeghi, S., Hadizadeh, M., Talebzade, T., & Houshmand, M. (2019). Evaluation of FTO rs9939609 and MC4R rs17782313 Polymorphisms as Prognostic Biomarkers of Obesity: A Population-based Cross-sectional Study. Oman Medical Journal, 34(1), 56–62. https://doi.org/10.5001/omj.2019.09

Nasr, H. B., Dimassi, S., M’hadhbi, R., Debbabi, H., Kortas, M., Tabka, Z., & Chahed, K. (2016). Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians. Obesity Research & Clinical Practice, 10(4), 465–475. https://doi.org/10.1016/j.orcp.2015.04.008

Netto, B. D. M., Bettini, S. C., Clemente, A. P. G., Ferreira, J. P. de C., Boritza, K., Souza, S. de F., … Dâmaso, A. R. (2015). Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obesity Surgery, 25(6), 1010–1018. https://doi.org/10.1007/s11695-014-1484-7

Nimptsch, K., Konigorski, S., & Pischon, T. (2019). Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism: Clinical and Experimental, 92, 61–70. https://doi.org/10.1016/j.metabol.2018.12.006

Nimptsch, K., & Pischon, T. (2016). Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer, 208, 199–217. https://doi.org/10.1007/978-3-319-42542-9_11

Olza, J., Ruperez, A. I., Gil-Campos, M., Leis, R., Fernandez-Orth, D., Tojo, R., … Aguilera, C. M. (2013). Influence of FTO variants on obesity, inflammation and cardiovascular disease risk biomarkers in Spanish children: a case-control multicentre study. BMC Medical Genetics, 14, 123. https://doi.org/10.1186/1471-2350-14-123

O’Neil, C. E., Nicklas, T. A., Rampersaud, G. C., & Fulgoni, V. L. (2012). 100% orange juice consumption is associated with better diet quality, improved nutrient adequacy, decreased risk for obesity, and improved biomarkers of health in adults: National Health and Nutrition Examination Survey, 2003-2006. Nutrition Journal, 11, 107. https://doi.org/10.1186/1475-2891-11-107

Osadnik, T., Bujak, K., Osadnik, K., Czarnecka, H., Pawlas, N., Reguła, R., … Gąsior, M. (2019). Novel inflammatory biomarkers may reflect subclinical inflammation in young healthy adults with obesity. Endokrynologia Polska, 70(2), 135–142. https://doi.org/10.5603/EP.a2019.0002

This entry was posted in Bioinformatics, Biomarkers, Obesity and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply